File Download
 
Links for fulltext
(May Require Subscription)
 
Supplementary

Article: A mixed-valent ruthenium-oxo oxalato cluster Na7[Ru 4(μ3-O)4(C2O4) 6] with potent anti-HIV activities
  • Basic View
  • Metadata View
  • XML View
TitleA mixed-valent ruthenium-oxo oxalato cluster Na7[Ru 4(μ3-O)4(C2O4) 6] with potent anti-HIV activities
 
AuthorsWong, ELM2
Sun, RWY2
Chung, NPY1
Lin, CLS1
Zhu, N2
Che, CM2
 
Issue Date2006
 
PublisherAmerican Chemical Society. The Journal's web site is located at http://pubs.acs.org/journals/jacsat/index.html
 
CitationJournal Of The American Chemical Society, 2006, v. 128 n. 15, p. 4938-4939 [How to Cite?]
DOI: http://dx.doi.org/10.1021/ja057883k
 
AbstractA structurally characterized mixed-valent tetranuclear ruthenium-oxo oxalato cluster exhibits anti-viral activities toward R5- and X4-tropic HIV-1, and possesses cytoprotective activity toward HIV-1 infected cells. Copyright © 2006 American Chemical Society.
 
ISSN0002-7863
2013 Impact Factor: 11.444
 
DOIhttp://dx.doi.org/10.1021/ja057883k
 
ReferencesReferences in Scopus
 
DC FieldValue
dc.contributor.authorWong, ELM
 
dc.contributor.authorSun, RWY
 
dc.contributor.authorChung, NPY
 
dc.contributor.authorLin, CLS
 
dc.contributor.authorZhu, N
 
dc.contributor.authorChe, CM
 
dc.date.accessioned2012-10-08T03:14:08Z
 
dc.date.available2012-10-08T03:14:08Z
 
dc.date.issued2006
 
dc.description.abstractA structurally characterized mixed-valent tetranuclear ruthenium-oxo oxalato cluster exhibits anti-viral activities toward R5- and X4-tropic HIV-1, and possesses cytoprotective activity toward HIV-1 infected cells. Copyright © 2006 American Chemical Society.
 
dc.description.naturelink_to_subscribed_fulltext
 
dc.identifier.citationJournal Of The American Chemical Society, 2006, v. 128 n. 15, p. 4938-4939 [How to Cite?]
DOI: http://dx.doi.org/10.1021/ja057883k
 
dc.identifier.doihttp://dx.doi.org/10.1021/ja057883k
 
dc.identifier.epage4939
 
dc.identifier.hkuros117884
 
dc.identifier.issn0002-7863
2013 Impact Factor: 11.444
 
dc.identifier.issue15
 
dc.identifier.pmid16608312
 
dc.identifier.scopuseid_2-s2.0-33646148274
 
dc.identifier.spage4938
 
dc.identifier.urihttp://hdl.handle.net/10722/168014
 
dc.identifier.volume128
 
dc.languageeng
 
dc.publisherAmerican Chemical Society. The Journal's web site is located at http://pubs.acs.org/journals/jacsat/index.html
 
dc.publisher.placeUnited States
 
dc.relation.ispartofJournal of the American Chemical Society
 
dc.relation.referencesReferences in Scopus
 
dc.subject.meshAnti-Hiv Agents - Chemistry - Pharmacology
 
dc.subject.meshCrystallography, X-Ray
 
dc.subject.meshEnzyme-Linked Immunosorbent Assay
 
dc.subject.meshFlow Cytometry
 
dc.subject.meshHiv Reverse Transcriptase - Antagonists & Inhibitors
 
dc.subject.meshHiv-1 - Physiology
 
dc.subject.meshHumans
 
dc.subject.meshIn Situ Nick-End Labeling
 
dc.subject.meshOrganometallic Compounds - Chemistry - Pharmacology
 
dc.subject.meshOxalates - Chemistry - Pharmacology
 
dc.subject.meshRuthenium - Chemistry - Pharmacology
 
dc.subject.meshT-Lymphocytes - Virology
 
dc.subject.meshVirus Replication - Drug Effects
 
dc.titleA mixed-valent ruthenium-oxo oxalato cluster Na7[Ru 4(μ3-O)4(C2O4) 6] with potent anti-HIV activities
 
dc.typeArticle
 
<?xml encoding="utf-8" version="1.0"?>
<item><contributor.author>Wong, ELM</contributor.author>
<contributor.author>Sun, RWY</contributor.author>
<contributor.author>Chung, NPY</contributor.author>
<contributor.author>Lin, CLS</contributor.author>
<contributor.author>Zhu, N</contributor.author>
<contributor.author>Che, CM</contributor.author>
<date.accessioned>2012-10-08T03:14:08Z</date.accessioned>
<date.available>2012-10-08T03:14:08Z</date.available>
<date.issued>2006</date.issued>
<identifier.citation>Journal Of The American Chemical Society, 2006, v. 128 n. 15, p. 4938-4939</identifier.citation>
<identifier.issn>0002-7863</identifier.issn>
<identifier.uri>http://hdl.handle.net/10722/168014</identifier.uri>
<description.abstract>A structurally characterized mixed-valent tetranuclear ruthenium-oxo oxalato cluster exhibits anti-viral activities toward R5- and X4-tropic HIV-1, and possesses cytoprotective activity toward HIV-1 infected cells. Copyright &#169; 2006 American Chemical Society.</description.abstract>
<language>eng</language>
<publisher>American Chemical Society. The Journal&apos;s web site is located at http://pubs.acs.org/journals/jacsat/index.html</publisher>
<relation.ispartof>Journal of the American Chemical Society</relation.ispartof>
<subject.mesh>Anti-Hiv Agents - Chemistry - Pharmacology</subject.mesh>
<subject.mesh>Crystallography, X-Ray</subject.mesh>
<subject.mesh>Enzyme-Linked Immunosorbent Assay</subject.mesh>
<subject.mesh>Flow Cytometry</subject.mesh>
<subject.mesh>Hiv Reverse Transcriptase - Antagonists &amp; Inhibitors</subject.mesh>
<subject.mesh>Hiv-1 - Physiology</subject.mesh>
<subject.mesh>Humans</subject.mesh>
<subject.mesh>In Situ Nick-End Labeling</subject.mesh>
<subject.mesh>Organometallic Compounds - Chemistry - Pharmacology</subject.mesh>
<subject.mesh>Oxalates - Chemistry - Pharmacology</subject.mesh>
<subject.mesh>Ruthenium - Chemistry - Pharmacology</subject.mesh>
<subject.mesh>T-Lymphocytes - Virology</subject.mesh>
<subject.mesh>Virus Replication - Drug Effects</subject.mesh>
<title>A mixed-valent ruthenium-oxo oxalato cluster Na7[Ru 4(&#956;3-O)4(C2O4) 6] with potent anti-HIV activities</title>
<type>Article</type>
<description.nature>link_to_subscribed_fulltext</description.nature>
<identifier.doi>10.1021/ja057883k</identifier.doi>
<identifier.pmid>16608312</identifier.pmid>
<identifier.scopus>eid_2-s2.0-33646148274</identifier.scopus>
<identifier.hkuros>117884</identifier.hkuros>
<relation.references>http://www.scopus.com/mlt/select.url?eid=2-s2.0-33646148274&amp;selection=ref&amp;src=s&amp;origin=recordpage</relation.references>
<identifier.volume>128</identifier.volume>
<identifier.issue>15</identifier.issue>
<identifier.spage>4938</identifier.spage>
<identifier.epage>4939</identifier.epage>
<publisher.place>United States</publisher.place>
</item>
Author Affiliations
  1. The University of Hong Kong
  2. Institute of Molecular Technology for Drug Discovery and Synthesis, Hong Kong